Amid Criticism, NCI Tries To Boost Minority Clinical-Trial Recruitment

Clinical-Trial Recruitment 'PLEASANT SUPRISE': NCI's Otis Brawley notes the racial makeup of treatment-trial patients was not planned. The National Cancer Institute (NCI), the largest of the National Institutes of Health, proudly touts its record of recruiting minorities into clinical trials it supports. "We have incredibly good representation of minorities on treatment trials," maintains Otis Brawley, senior investigator in the Community Oncology and Rehabilitation Branch of NCI's Division o

Written byMyrna Watanabe
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Clinical-Trial Recruitment

Otis Brawley
'PLEASANT SUPRISE': NCI's Otis Brawley notes the racial makeup of treatment-trial patients was not planned.
The National Cancer Institute (NCI), the largest of the National Institutes of Health, proudly touts its record of recruiting minorities into clinical trials it supports. "We have incredibly good representation of minorities on treatment trials," maintains Otis Brawley, senior investigator in the Community Oncology and Rehabilitation Branch of NCI's Division of Cancer Prevention and Control. NCI director Richard Klausner concurs, declaring that "for treatment trials, [minorities] are represented proportional to their percent for the disease."

Yet many scientists who work with minority communities doubt the strength of NCI's commitment to ensuring the inclusion of minority subjects in institute-sponsored research. They contend that these groups not only should be included in trials in proportional numbers, but also should be full participatory partners in the research protocols.

"Until we rely upon minority communities to instruct ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo
Explore new strategies for improving plasmid DNA manufacturing workflows.

Overcoming Obstacles in Plasmid DNA Manufacturing

cytiva logo

Products

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery

brandtechscientific-logo

BRANDTECH Scientific Launches New Website for VACUU·LAN® Lab Vacuum Systems